Gene Therapy for Male Patients With Danon Disease (DD) Using RP-A501; AAV9.LAMP2B

NCT03882437 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
7
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Rocket Pharmaceuticals Inc.